APA

MacLean D. B., Matsui H., Suri A., Neuwirth R. & Colombel M. (20141027). Sustained exposure to the investigational Kisspeptin analog, TAK-448, down-regulates testosterone into the castration range in healthy males and in patients with prostate cancer: results from two phase 1 studies. : The Journal of clinical endocrinology and metabolism.

Chicago

MacLean David B, Matsui Hisanori, Suri Ajit, Neuwirth Rachel and Colombel Marc. 20141027. Sustained exposure to the investigational Kisspeptin analog, TAK-448, down-regulates testosterone into the castration range in healthy males and in patients with prostate cancer: results from two phase 1 studies. : The Journal of clinical endocrinology and metabolism.

Harvard

MacLean D. B., Matsui H., Suri A., Neuwirth R. and Colombel M. (20141027). Sustained exposure to the investigational Kisspeptin analog, TAK-448, down-regulates testosterone into the castration range in healthy males and in patients with prostate cancer: results from two phase 1 studies. : The Journal of clinical endocrinology and metabolism.

MLA

MacLean David B, Matsui Hisanori, Suri Ajit, Neuwirth Rachel and Colombel Marc. Sustained exposure to the investigational Kisspeptin analog, TAK-448, down-regulates testosterone into the castration range in healthy males and in patients with prostate cancer: results from two phase 1 studies. : The Journal of clinical endocrinology and metabolism. 20141027.